Development and validation of a prediction model for 1-year mortality among older adults with Hodgkin Lymphoma who receive dose-intense chemotherapy

Keyphrases

• Older Adults 100%
• Prediction Model 100%
• 1-year Mortality 100%
• Hodgkin Lymphoma 100%
• Dose-dense Chemotherapy 100%
• Validation Cohort 60%
• Older Patients 40%
• Charlson Comorbidity Index 40%
• C-statistic 40%
• Advanced Stage 40%
• B Symptoms 40%
• Final Model 40%
• Working Diagnosis 20%
• Young Patients 20%
• Disease Factor 20%
• Chemotherapy 20%
• Logistic Regression 20%
• Age at Diagnosis 20%
• Year of Diagnosis 20%
• Poor Outcome 20%
• Medicare 20%
• Patient Characteristics 20%
• Identify Risk 20%
• Old Age 20%
• Surveillance Epidemiology 20%
• Significant Predictors 20%
• Little Data 20%
• New Diagnosis 20%
• Classical Hodgkin Lymphoma 20%
• Shared Decision Making 20%
• Diagnosis Stage 20%
• Stage at Diagnosis 20%
• Mortality Factors 20%
• Multiple Imputation 20%
• Missing Data 20%
• Received Dose 20%
• Stepwise Selection 20%
• Predictive Variables 20%
• Intensive Chemotherapy 20%

Medicine and Dentistry

• Hodgkin's Lymphoma 100%
• Charlson Comorbidity Index 50%
• B Symptoms 50%
• Medicare 25%
• Logistic Regression Analysis 25%
• Surveillance, Epidemiology, and End Results 25%
• Classical Hodgkin Lymphoma 25%
• Prognostication 25%
• Shared Decision Making 25%
• Chemotherapy 25%
• Diseases 25%

Immunology and Microbiology

• Comorbidity 100%
• Shared Decision Making 50%
• Cohort Effect 50%